Replies to post #675 on LadRx Corp (LADXD)

[$King]

CYTR @ .384

[Ecomike]

Like I have said here before, CYTR is sitting on some blockbuster drugs!!! Every PR I have read in the last 18 months or more on the drug trial results from CYTR has had huge positive (some surprisingly more positive them hoped for) results, and here is one more today!!!

Of five patients who have completed four cycles with INNO-206 at the maximum tolerated dose, one patient has exhibited a partial tumor response (greater than 30% tumor shrinkage) and four patients have stable disease. Unexpectedly, a large, painful oral sarcoma that caused difficulty eating in one patient was greatly reduced following a single INNO-206 treatment.

[surf1944]

8:33AM CytRx announces the presentation of favorable phase 2 clinical results with Bafetinib in relapsed B-Cell Chronic Lymphocytic Leukemia at ASH conference (CYTR) 0.33 : Each of the 18 late-stage B-CLL patients enrolled in the ENABLE trial had been treated with and failed between one and six therapies, with a median of three, and 14 of the 18 patients (87%) having unfavorable cytogenetics. Patients were treated with orally administered bafetinib twice daily. Six of 12 (50%) of the evaluable patients achieved 30% or greater shrinkage of the lymph node and spleen, and four of 12 (33%) patients had stable disease. No serious adverse events were observed at the dose of 240 mg twice daily, which is the dose that would likely be used in any future clinical trials in chronic lymphocytic leukemia. Two patients remain in the trial, which is being conducted at the M.D. Anderson Cancer Center and City of Hope Medical Center.